Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 7, 2012, Pages 1165-1170

  Pan, Manuel ^a   Medina, Alfonso ^b   Suárez De Lezo, Jose ^a   Romero, Miguel ^a   Segura, Jose ^a   Martín, Pedro ^b   Suárez De Lezo, Javier ^a   Hernandez, Enrique ^b   Mazuelos, Francisco ^a   Ojeda, Soledad ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

bifurcation lesions; drug eluting stents

Indexed keywords

EVEROLIMUS; RAPAMYCIN; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON DILATATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY BIFURCATION LESION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART REINFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION;

AGED; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; SPAIN; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84870917863     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24281     Document Type: Article

References (25)

1. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB,. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
2. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, Delgado A, Ojeda S, Melian F, Herrador J, Ureña I, Burgos L,. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. Am Heart J 2004; 148: 857-864.
3. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemela M, Kervinen K, Jensen JS, Galløe A, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L,; Nordic PCI Study Group. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation 2006; 114: 1955-1961.
4. Ferenc M, Gick M, Kienzle RP, Bestehorn HP, Werner KD, Comberg T, Kuebler P, Büttner HJ, Neumann FJ,. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J 2008; 29: 2859-2867.
5. Colombo A, Bramucci E, Sacca' S, Violini R, Lettieri C, Zanini R, Sheiban I, Paloscia L, Grube E, Schofer J, Bolognese L, Orlandi M, Niccoli G, Latib A, Airoldi F,. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations. The CACTUS (coronary bifurcations: Application of the crushing technique using sirolimus-eluting stents) study. Circulation 2009; 119: 71-78.
6. Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, Bennett L, Holmberg S, Cotton JM, Glennon PE, Thomas MR, Maccarthy PA, Baumbach A, Mulvihill NT, Henderson RA, Redwood SR, Starkey IR, Stables RH,. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: The British Bifurcation Coronary Study: Old, new, and evolving strategies. Circulation 2010; 121: 1235-1243.
7. Heras M, Avanzas P, Bayes-Genis A, Pan M, Perez de Isla L, Sanchis J,. Unplanned redundant publications: A consequence of too many cardiovascular journals? Eurointervention 2010; 6: 179-181.
8. Pan M, Suarez de Lezo J, Medina A, Romero M, Delgado A, Segura J, Ojeda S, Mazuelos F, Hernandez E, Melian F, Pavlovic DJ, Esteban F, Herrador J,. Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007; 153: 15.e1215.e7.
9. Song YB, Hahn JY, Choi SH, Choi JH, Lee SH, Jeong MH, Kim HS, Seong IW, Yang JY, Rha SW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park SJ, Gwon HC,. Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: From the COBIS (Coronary Bifurcation Stenting) Registry. J Am Coll Cardiol 2010; 55: 1743-1750.
10. Pan M, Suárez de Lezo J, Medina A, Romero M, Segura J, Ramírez A, Pavlovic D, Hernández E, Ojeda S, Adamuz C,. A stepwise strategy for the stent treatment of bifurcated coronary lesions. Catheter Cardiovasc Interv 2002; 55: 50-57.
11. Medina A, Suarez de Lezo J, Pan M,. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006; 59: 183-184.
12. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW,; for Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
13. Zhang F, Dong L, Ge J,. Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: A metaanalysis of randomised trials. Heart 2009; 95: 1676-1681.
14. Hakeem A, Khan FM, Bhatti S, Samad Z, Effat MA, Eckman MH, Helmy T,. Provisional vs. complex stenting strategy for coronary bifurcation lesions: Meta-analysis of randomized trials. J Invasive Cardiol 2009; 21: 589-595.
15. Katritsis DG, Siontis GCM, Ioannidis JPA,. Double versus single stenting for coronary bifurcation lesions. A meta-analysis. Circ Cardiovasc Intervent 2009; 2: 409-415.
16. Brar SJ, Gray WA, Dangas G, Leon MB, Aharonian VJ, Brar SK, Moses JW,. Bifurcation stenting with drug-eluting stents: A systematic review and meta-analysis of randomised trials. Eurointervention 2009; 5: 475-484.
17. Athappana G, Ponniahb T, Jeyaseelanc L,. True coronary bifurcation lesions: Meta-analysis and review of literature. J Cardiovasc Med 2010; 11: 103-110.
18. Guérin P, Pilet P, Finet G, Gouëffic Y, N'Guyen JM, Crochet D, Tijou I, Pacaud P, Loirand G,. Drug-eluting stents in bifurcations bench study of strut deformation and coating lesions. Circ Cardiovasc Interv 2010; 3: 120-126.
19. Mortier P, De Beulea M, Van Loob D, Verhegghea B, Verdoncka P,. Finite element analysis of side branch access during bifurcation stenting. Med Eng Phys 2009; 31: 434-440.
20. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ,; SPIRIT III Investigators. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease. A randomized trial. JAMA 2008; 299: 1903-1913.
21. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ,; SPIRIT IV Investigators. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010; 362: 1663-1674.
22. Jensen LO, Thayssen P, Tilsted HH, Ravkilde J, Junker A, Hansen HS, Hansen KN, Pedersen KE, Sørensen HT, Thuesen L, Lassen JF,; Scandinavian Organization for Randomized Trials with Clinical Outcome SORT OUT IV investigators. Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease. Cardiology 2010; 116: 73-78.
23. Park KW, Chae IH, Lim DS, Han KR, Yang HM, Lee HY, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Jo SH, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Gwon HC, Jang YS, Kim HS,. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention. The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial. J Am Coll Cardiol 2011; 58: 1844-1854.
24. de la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, Pérez de Prado A, Rivero F, Sanchis J, Larman M, Diaz JF, Elizaga J, Moreiras JM, Gomez Jaume A, Hernández JM, Mauri J, Recalde AS, Bullones JA, Rumoroso JR, Del Blanco BG, Baz JA, Bosa F, Botas J, Hernández F,; ESTROFA-2 Study Group. Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2). JACC Cardiovasc Interv 2010; 3: 911-919.
25. Burzotta F, Trani C, Todaro D, Mariani L, Talarico GP, Tommasino A, Giammarinaro M, Niccoli G, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F,. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach. JACC Cardiovasc Interv 2011; 4: 327-335.